Dasgupta, RananCameron, SarahAucott, LornaMacLennan, GraemeThomas, RuthN'Dow, JamesNorrie, JohnAnson, KenKeeley Jr, Francis X.MacLennan, SaraStarr, KathrynMcClinton, SamKilonzo, MaryLam, Thomas2025-06-232025-06-232021-07-01Dasgupta, R, Cameron, S, Aucott, L, MacLennan, G, Thomas, R, N'Dow, J, Norrie, J, Anson, K, Keeley Jr, F X, MacLennan, S, Starr, K, McClinton, S, Kilonzo, M & Lam, T 2021, 'Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU) : A Multicentre Randomised Controlled Non-inferiority Trial', European Urology, vol. 80, no. 1, pp. 46-54. https://doi.org/10.1016/j.eururo.2021.02.0440302-2838ORCID: 0000-0001-8044-8902ORCID: /0000-0003-1405-6964/work/91891825ORCID: /0000-0001-6277-7972/work/91891866ORCID: /0000-0002-1039-5646/work/98038543ORCID: /0000-0002-8316-2616/work/161798369ORCID: /0000-0001-5340-0081/work/162725321ORCID: /0000-0002-3450-4536/work/170010815https://hdl.handle.net/2164/25596Funding/Support and role of the sponsor: This paper presents independent research funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme, Project Number 10/137/01. The views and opinions expressed in this report are those of the authors and do not necessarily reflect those of the HTA Programme, the NIHR, the NHS, or the Department of Health. The Health Services Research Unit is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates; however, the opinions expressed in this publication are those of the authors and might not be shared by the Chief Scientist Office. Acknowledgements: Special thanks must go to all of the TISU trial participants and staff at each of our recruiting centres for taking part in this trial. We thank our collaborators at the TISU sites, and participating National Health Service (NHS) trusts and boards (the Newcastle upon Tyne Hospitals NHS Foundation Trust, South Tees Hospitals NHS Foundation Trust, City Hospitals Sunderland NHS Foundation Trust, the Leeds Teaching Hospitals NHS Trust, University Hospitals Bristol NHS Trust, NHS Lothian, Guy’s and St Thomas’ NHS Foundation Trust, St George’s Healthcare NHS Trust, Mid Yorkshire Hospitals NHS Trust, Sheffield Teaching Hospitals NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Central Manchester University Hospitals NHS Foundation Trust, Betsi Cadwaladr University Health Board, Dartford and Gravesham NHS Trust, St Helens & Knowsley Teaching Hospital NHS Trust, Ashford & St Peters Hospitals NHS Foundation Trust, Imperial College Healthcare NHS Trust, Northwest London Hospital NHS Trust, Mid-Essex Hospital NHS Trust, Salford Royal NHS Foundation Trust, Oxford University Hospitals Trust, East Kent Hospitals University NHS Foundation Trust, Hull and East Yorkshire Hospitals NHS Trust, Derby Hospital NHS Foundation trust, Bradford Teaching Hospitals NHS Foundation Trust, and the University Hospital of South Manchester NHS Foundation Trust). We thank the staff at the TISU trial office based in the Centre for Healthcare Randomised Trials (CHaRT) within the Health Services Research Unit, University of Aberdeen.9884262engTherapeutic interventions for symptomatic ureteric stonesUreteric stonesUreteroscopyExtracorporeal shockwave lithotripsyTrialRandomised controlled trialR MedicineNational Institute for Health Research (NIHR)10/137/01Supplementary DataRJournal article10.1016/j.eururo.2021.02.044801